A clinical evaluation of risperidone in the treatment of schizophrenia: a 10-week, open-label, multicenter trial
โ Scribed by D. V. Jeste; Mark Klausner; Martin Brecher; Christopher Clyde; Robert Jones; ARCS Study Group
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 259 KB
- Volume
- 131
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Objective To evaluate the effectiveness of antipsychotic polypharmacy in a methodologically sound manner. ## Methods In this openโlabel study, 17 patients with treatmentโrefractory schizophrenia, who failed to respond to a sequential monotherapy with olanzapine, quetiapine and ris
## Abstract The study aimed to evaluate the efficacy of longโacting injectable risperidone (LAR) in Asian patients with schizophrenia spectrum disorders. Twentyโfive patients enrolled in this 6โmonth open labelled study. They were switched from their current antipsychotic to LAR without a prior or